MedPath

Investigating the impact of FREO2 technology on access to oxygen therapy for children in Uganda.

Not Applicable
Recruiting
Conditions
Hypoxaemia
Respiratory - Other respiratory disorders / diseases
Public Health - Health service research
Registration Number
ACTRN12621000241831
Lead Sponsor
FREO2 Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
6000
Inclusion Criteria

All neonatal and paediatric admission to included facilities.

Exclusion Criteria

No exclusion criteria.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of children with hypoxaemia who receive oxygen pre and post intervention. Medical records are reviewed weekly by study personnel to record number of hypoxaemia admissions (children with SpO2<90% on admission), and whether they received oxygen. These data will be entered on RedCAP forms. [Pre-post intervention comparison. 3 months pre-intervention period, and 3 months post-intervention. ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath